广告A Key Goal In First-Line HR+ mBC Is To Maximize Patients' Time On Endocrine Therapy. Endocrine Resistance May Lead To Poor 1L Treatment Response. Rethink ET.

广告Discover the Verzenio® MOA. Explore Verzenio® as a treatment option for your patients.